NEW DELHI, Dec 7 (Reuters) - India is considering reviewing
Pfizer Inc and AstraZeneca's vaccines for
emergency use on an accelerated basis, a senior government
official said on Monday.
Serum Institute is making AstraZeneca's COVID-19 vaccine in
India and has applied for emergency use authorization.
Pfizer applied for emergency use authorization of its
coronavirus vaccine over the weekend, the official said.
"We are in the process of reviewing. It is an accelerated
reviewing process, which is there for Serum too," the government
official said. "All applications are accelerated. It is the need
of the hour."
(Reporting by Neha Arora in New Delhi; Editing by Catherine
Evans)